PGNY

Progyny Inc

PGNY.US progyny.com
27.08
-0.04 (-0.15%)
USD · NASDAQ
52-week range
16.10
33.07
Trading at 65% of the 52-week range
Market Cap
2.08B
P/E Ratio
29.48
Forward P/E
12.45
Book Value
5.90
Div. Yield
N/A
% Institutions
110.84%
% Insiders
1.99%

1 Year

+19.7%

3 Year

-26.9%

10 Year

+69.9%
Description

Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services, as well as pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions. In addition, it provides assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Company Information

Company Name
Progyny Inc
Sector
Healthcare
Industry
Healthcare Plans
Exchange
NASDAQ
ISIN: US74340E1038
CIK: 0001551306
CUSIP: 74340E103
Currency: USD
Full Time Employees: 835
Phone: 212 888 3124
Website: progyny.com
Fiscal Year End: December
IPO Date: Oct 25, 2019
Description:

Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services, as well as pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions. In addition, it provides assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Address:

1359 Broadway, New York, NY, United States, 10018

People

Directors & Officers

Name Title Year Born
Mr. David J. Schlanger J.D. Executive Chairman 1959
Mr. Peter Anevski CPA CEO & Director 1967
Mr. Mark S. Livingston CPA Chief Financial Officer 1966
Ms. Melissa B. Cummings Chief Operating Officer 1970
Ms. Allison Swartz Executive VP, General Counsel & Secretary 1990
Mr. Geoffrey Clapp Chief Product Officer 1974
Mr. Steven Leist Chief Technology Officer NA
Mr. James Hart Vice President of Investor Relations NA
Ms. Risa Fisher Chief Marketing Officer NA
Ms. Cassandra Pratt Chief Human Resources Officer NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 04, 2026 Allison Swartz N/A Sale 599.00 $17.54 $10.51K
Mar 03, 2026 Allison Swartz N/A Sale 4.66K $17.40 $81.03K
Mar 02, 2026 Allison Swartz N/A Sale 2.20K $17.27 $37.98K
Dec 04, 2025 Allison Swartz N/A Sale 530.00 $24.59 $13.03K
Dec 02, 2025 Mark S Livingston N/A Sale 213.00 $25.50 $5.43K
Nov 17, 2025 Mark S Livingston N/A Sale 21.30K $25.50 $543.23K
Nov 13, 2025 Peter Anevski N/A Purchase 79.50K $24.29 $1.93M
Sep 04, 2025 Allison Swartz N/A Sale 599.00 $23.53 $14.09K
Aug 28, 2025 Allison Swartz N/A Sale 2.40K $22.96 $55.06K
Aug 28, 2025 Allison Swartz N/A Sale 2.40K $22.96 $55.06K
Aug 11, 2025 Kevin K Gordon N/A Sale 2.50K $22.04 $55.10K
Jun 11, 2025 Cheryl Scott N/A Sale 2.68K $22.07 $59.04K

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 12.00M Mar 31, 2026 15.50% $0.00 -7.41%
FMR Inc 6.50M Mar 31, 2026 8.40% $0.01 -1.01%
Vanguard Portfolio Management, LLC 5.29M Mar 31, 2026 6.84% $0.00 0.00%
Vanguard Capital Management, LLC 3.48M Mar 31, 2026 4.50% $0.00 0.00%
State Street Corp 3.08M Mar 31, 2026 3.98% $0.00 4.30%
Ameriprise Financial Inc 2.83M Mar 31, 2026 3.65% $0.01 24.02%
Fort Washington Investment Advisors Inc 2.55M Jun 30, 2026 3.29% $0.37 -5.39%
Morgan Stanley - Brokerage Accounts 2.29M Mar 31, 2026 2.96% $0.00 77.80%
Geode Capital Management, LLC 2.04M Mar 31, 2026 2.64% $0.00 3.59%
Dimensional Fund Advisors, Inc. 1.69M Jun 30, 2026 2.18% $0.01 7.32%
Soleus Capital Management, L.P. 1.60M Jun 30, 2026 2.07% $1.59 -22.50%
Wellington Management Company LLP 1.50M Jun 30, 2026 1.93% $0.01 -34.57%
Bank of America Corp 1.19M Mar 31, 2026 1.54% $0.00 75.30%
Disciplined Growth Investors Inc 1.18M Jun 30, 2026 1.53% $0.58 105.66%
Loomis, Sayles & Company LP 1.08M Jun 30, 2026 1.40% $0.04 9.36%
Baillie Gifford & Co Limited. 1.08M Jun 30, 2026 1.39% $0.03 -11.64%
Easterly Investment Partners. 958.12K Jun 30, 2026 1.24% $1.41 0.00%
LSV Asset Management 895.64K Jun 30, 2026 1.16% $0.05 5,107.19%
Allianz Asset Management AG 855.45K Mar 31, 2026 1.11% $0.02 -0.72%
Northern Trust Corp 818.18K Mar 31, 2026 1.06% $0.00 0.78%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 iShares Core S&P Small-Cap ETF 4.44M 5.74% ▲ 0.03% Aug 31, 2026
2 Fort Washington Small Company Equity 2.47M 3.19% ▼ 5.12% Jun 30, 2026
3 Small Company Equity - FTWA 2.47M 3.19% ▼ 5.12% Jun 30, 2026
4 Vanguard MStar Total Stk Mkt Idx Invest 2.25M 2.91% ▲ 0.40% Jul 31, 2026
5 Touchstone Small Company A 1.94M 2.51% ▼ 1.10% Jun 30, 2026
6 iShares Russell 2000 ETF 1.78M 2.30% ▼ 0.57% Aug 31, 2026
7 Fidelity Small Cap Growth 1.68M 2.17% ▲ 0.00% Jun 30, 2026
8 Avantis US Small Cap Value ETF 1.66M 2.14% ▲ 1.36% Aug 31, 2026
9 Vanguard Small Cap Index 1.62M 2.09% ▲ 0.49% Jul 31, 2026
10 CT (Lux) American Smaller Com 9U USD 1.52M 1.97% ▲ 2.40% Jul 31, 2026

Financial Highlights

Market Cap: $2.08B
EBITDA: $125.57M
P/E Ratio: $29.48
Book Value: $5.90
Earnings/Share: $0.92
Profit Margin: 6.00%
Operating Margin: 11.41%
ROA (TTM): 10.14%
ROE (TTM): 16.24%
Revenue (TTM): $1.31B
Revenue/Share (TTM): $15.87
Earnings Growth (YOY): 78.90%
Revenue Growth (YOY): 5.30%

Valuation Metrics

Enterprise Value: $1.87B
Trailing P/E: 29.48
Forward P/E: 12.45

Shares Statistics

Shares Outstanding: 76.73M
Shares Float: 70.15M
% Insiders: 1.99%
% Institutions: 110.84%
Short % Float: 8.42%

Stock Price History

1 Year Price History

3 Years Price History

10 Years Price History

Financial Charts

Revenue, Net Income & Operating Cash Flow (Yearly)

Revenue, Net Income & Operating Cash Flow (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$1.29B
Cost of Goods Sold
adjust
$-984.18M
Gross Profit
subtotal
$304.48M
SG&A
adjust
$-147.09M
Other Operating Expense
adjust
$-72.11M
Operating Income
subtotal
$85.28M
Other / Non-Operating Items
adjust
$-26.76M
Net Income
subtotal
$58.52M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about PGNY.US!